On May 2017, Ransomware attack suspended UK healthcare system services. It shown the security weakness in hospital and clinic IT system infrastructure. BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. A vulnerabilitiy found on Becton Dickinson causes a series of products being effected. It includes BD Kiestra TLA, BD Kiestra WCA and BD InoqulA+ specimen processor. The vendor state that this vulnerability cannot be exploited remotely. You must have physical access to the sub-network shared by the BD Kiestra system.According to the vendor solution , their product allow both thick client and thin client (web base) access. And therefore the vendor requires to remind the client who engaged the web base function to staying alert. Should you have interested to find out the details. Please refer below url for reference.